Amgen Raises FY2026 Adj EPS Guidance from $22.30-$23.50 to $22.90-$23.70 vs $23.02 Est; Raises FY2026 Sales Guidance from $38.200B-$39.400B to $38.900B-$39.700B vs $38.936B Est
Benzinga Newsdesk 9 hours ago
NewsGuidanceHot
Amgen (NASDAQ:AMGN) raises FY2026 Adj EPS guidance from $22.30-$23.50 to $22.90-$23.70 vs $23.02 analyst estimate. Raises FY2026 sales outlook from $38.200 billion-$39.400 billion to $38.900 billion-$39.700 billion vs
Amgen (NASDAQ:AMGN) raises FY2026 Adj EPS guidance from $22.30-$23.50 to $22.90-$23.70 vs $23.02 analyst estimate. Raises FY2026 sales outlook from $38.200 billion-$39.400 billion to $38.900 billion-$39.700 billion vs $38.936 billion estimate.